Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zihua Wenfei Zhishou granules is a Traditional Chinese Medicine (TCM) formulation developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of post-infectious cough (PIC). It is specifically indicated for patients presenting with the 'wind-cold lingering in the lung' pattern, a TCM diagnosis characterized by persistent cough following an acute respiratory infection. The formulation is designed to warm the lungs, dispel cold, and relieve cough. It has undergone Phase II clinical testing in China (CTR20190931) to evaluate its safety and antitussive efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zihua Wenfei Zhishou granules.